naimad medical ltd Company Information
Company Number
11031209
Next Accounts
Dec 2025
Shareholders
tayza damian jude aung
helen lesley davison
Group Structure
View All
Industry
General medical practice activities
Registered Address
8 the courtyard wyncolls road, severalls industrial park, colchester, essex, CO4 9PE
Website
-naimad medical ltd Estimated Valuation
Pomanda estimates the enterprise value of NAIMAD MEDICAL LTD at £69.9k based on a Turnover of £126.8k and 0.55x industry multiple (adjusted for size and gross margin).
naimad medical ltd Estimated Valuation
Pomanda estimates the enterprise value of NAIMAD MEDICAL LTD at £74.5k based on an EBITDA of £18.2k and a 4.09x industry multiple (adjusted for size and gross margin).
naimad medical ltd Estimated Valuation
Pomanda estimates the enterprise value of NAIMAD MEDICAL LTD at £507.5k based on Net Assets of £202.1k and 2.51x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Naimad Medical Ltd Overview
Naimad Medical Ltd is a live company located in colchester, CO4 9PE with a Companies House number of 11031209. It operates in the general medical practice activities sector, SIC Code 86210. Founded in October 2017, it's largest shareholder is tayza damian jude aung with a 50% stake. Naimad Medical Ltd is a young, micro sized company, Pomanda has estimated its turnover at £126.8k with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Naimad Medical Ltd Health Check
Pomanda's financial health check has awarded Naimad Medical Ltd a 5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 4 areas for improvement. Company Health Check FAQs


5 Strong

2 Regular

4 Weak

Size
annual sales of £126.8k, make it smaller than the average company (£2m)
- Naimad Medical Ltd
£2m - Industry AVG

Growth
3 year (CAGR) sales growth of 13%, show it is growing at a faster rate (10.5%)
- Naimad Medical Ltd
10.5% - Industry AVG

Production
with a gross margin of 39.9%, this company has a comparable cost of product (39.9%)
- Naimad Medical Ltd
39.9% - Industry AVG

Profitability
an operating margin of 13.3% make it more profitable than the average company (3.7%)
- Naimad Medical Ltd
3.7% - Industry AVG

Employees
with 4 employees, this is below the industry average (23)
4 - Naimad Medical Ltd
23 - Industry AVG

Pay Structure
on an average salary of £34.6k, the company has an equivalent pay structure (£34.6k)
- Naimad Medical Ltd
£34.6k - Industry AVG

Efficiency
resulting in sales per employee of £31.7k, this is less efficient (£86.6k)
- Naimad Medical Ltd
£86.6k - Industry AVG

Debtor Days
it gets paid by customers after 5 days, this is earlier than average (30 days)
- Naimad Medical Ltd
30 days - Industry AVG

Creditor Days
its suppliers are paid after 1 days, this is quicker than average (25 days)
- Naimad Medical Ltd
25 days - Industry AVG

Stock Days
There is insufficient data available for this Key Performance Indicator!
- Naimad Medical Ltd
- - Industry AVG

Cash Balance
has cash to cover current liabilities for 1238 weeks, this is more cash available to meet short term requirements (39 weeks)
1238 weeks - Naimad Medical Ltd
39 weeks - Industry AVG

Debt Level
it has a ratio of liabilities to total assets of 3.4%, this is a lower level of debt than the average (55.9%)
3.4% - Naimad Medical Ltd
55.9% - Industry AVG
NAIMAD MEDICAL LTD financials

Naimad Medical Ltd's latest turnover from March 2024 is estimated at £126.8 thousand and the company has net assets of £202.1 thousand. According to their latest financial statements, Naimad Medical Ltd has 4 employees and maintains cash reserves of £171.2 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | |
---|---|---|---|---|---|---|---|
Turnover | |||||||
Other Income Or Grants | |||||||
Cost Of Sales | |||||||
Gross Profit | |||||||
Admin Expenses | |||||||
Operating Profit | |||||||
Interest Payable | |||||||
Interest Receivable | |||||||
Pre-Tax Profit | |||||||
Tax | |||||||
Profit After Tax | |||||||
Dividends Paid | |||||||
Retained Profit | |||||||
Employee Costs | |||||||
Number Of Employees | 4 | 4 | 3 | 2 | 2 | 2 | 2 |
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | |
---|---|---|---|---|---|---|---|
Tangible Assets | 1,327 | 2,401 | 1,790 | 3,947 | 2,984 | 1,474 | 943 |
Intangible Assets | |||||||
Investments & Other | |||||||
Debtors (Due After 1 year) | |||||||
Total Fixed Assets | 1,327 | 2,401 | 1,790 | 3,947 | 2,984 | 1,474 | 943 |
Stock & work in progress | |||||||
Trade Debtors | 1,845 | 3,990 | 3,450 | 3,950 | 2,475 | 3,480 | 4,610 |
Group Debtors | |||||||
Misc Debtors | 5,294 | 5,279 | 850 | 373 | 373 | 2 | |
Cash | 171,160 | 169,778 | 169,786 | 119,821 | 91,678 | 56,804 | 5,108 |
misc current assets | 29,656 | 9,071 | |||||
total current assets | 207,955 | 188,118 | 174,086 | 124,144 | 94,526 | 60,284 | 9,720 |
total assets | 209,282 | 190,519 | 175,876 | 128,091 | 97,510 | 61,758 | 10,663 |
Bank overdraft | |||||||
Bank loan | |||||||
Trade Creditors | 361 | ||||||
Group/Directors Accounts | 312 | 312 | |||||
other short term finances | |||||||
hp & lease commitments | |||||||
other current liabilities | 6,511 | 7,434 | 13,565 | 9,311 | 10,265 | 11,119 | 2,767 |
total current liabilities | 7,184 | 7,746 | 13,565 | 9,311 | 10,265 | 11,119 | 2,767 |
loans | |||||||
hp & lease commitments | |||||||
Accruals and Deferred Income | |||||||
other liabilities | |||||||
provisions | |||||||
total long term liabilities | |||||||
total liabilities | 7,184 | 7,746 | 13,565 | 9,311 | 10,265 | 11,119 | 2,767 |
net assets | 202,098 | 182,773 | 162,311 | 118,780 | 87,245 | 50,639 | 7,896 |
total shareholders funds | 202,098 | 182,773 | 162,311 | 118,780 | 87,245 | 50,639 | 7,896 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | |
---|---|---|---|---|---|---|---|
Operating Activities | |||||||
Operating Profit | |||||||
Depreciation | 1,404 | 249 | 2,157 | 2,085 | 1,916 | 790 | 56 |
Amortisation | |||||||
Tax | |||||||
Stock | |||||||
Debtors | -2,130 | 4,969 | -23 | 1,475 | -632 | -1,132 | 4,612 |
Creditors | 361 | ||||||
Accruals and Deferred Income | -923 | -6,131 | 4,254 | -954 | -854 | 8,352 | 2,767 |
Deferred Taxes & Provisions | |||||||
Cash flow from operations | |||||||
Investing Activities | |||||||
capital expenditure | |||||||
Change in Investments | |||||||
cash flow from investments | |||||||
Financing Activities | |||||||
Bank loans | |||||||
Group/Directors Accounts | 312 | ||||||
Other Short Term Loans | |||||||
Long term loans | |||||||
Hire Purchase and Lease Commitments | |||||||
other long term liabilities | |||||||
share issue | |||||||
interest | |||||||
cash flow from financing | |||||||
cash and cash equivalents | |||||||
cash | 1,382 | -8 | 49,965 | 28,143 | 34,874 | 51,696 | 5,108 |
overdraft | |||||||
change in cash | 1,382 | -8 | 49,965 | 28,143 | 34,874 | 51,696 | 5,108 |
naimad medical ltd Credit Report and Business Information
Naimad Medical Ltd Competitor Analysis

Perform a competitor analysis for naimad medical ltd by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in CO4 area or any other competitors across 12 key performance metrics.
naimad medical ltd Ownership
NAIMAD MEDICAL LTD group structure
Naimad Medical Ltd has no subsidiary companies.
Ultimate parent company
NAIMAD MEDICAL LTD
11031209
naimad medical ltd directors
Naimad Medical Ltd currently has 4 directors. The longest serving directors include Miss Helen Davison (Oct 2017) and Dr Tayza Aung (Oct 2017).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Miss Helen Davison | England | 52 years | Oct 2017 | - | Director |
Dr Tayza Aung | United Kingdom | 56 years | Oct 2017 | - | Director |
Mr Benedict Aung | United Kingdom | 22 years | Feb 2021 | - | Director |
Miss Sophia Aung | United Kingdom | 20 years | Jun 2022 | - | Director |
P&L
March 2024turnover
126.8k
-22%
operating profit
16.8k
0%
gross margin
39.9%
-3.18%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
202.1k
+0.11%
total assets
209.3k
+0.1%
cash
171.2k
+0.01%
net assets
Total assets minus all liabilities
naimad medical ltd company details
company number
11031209
Type
Private limited with Share Capital
industry
86210 - General medical practice activities
incorporation date
October 2017
age
8
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
March 2024
previous names
N/A
accountant
-
auditor
-
address
8 the courtyard wyncolls road, severalls industrial park, colchester, essex, CO4 9PE
Bank
-
Legal Advisor
-
naimad medical ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to naimad medical ltd.
naimad medical ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for NAIMAD MEDICAL LTD. This can take several minutes, an email will notify you when this has completed.
naimad medical ltd Companies House Filings - See Documents
date | description | view/download |
---|